(Q44539014)

3 December 2017

title

Chitosan inhibits prostaglandin E2 formation and cyclooxygenase-2 induction in lipopolysaccharide-treated RAW 264.7 macrophages (English)

1 reference

3 December 2017

1 reference

1 reference

Tz-Chong Chou

1

1 reference

3 December 2017

Earl Fu

series ordinal

2

1 reference

3 December 2017

E-Chin Shen

series ordinal

3

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

Biochemical and Biophysical Research Communications

3 December 2017

published in

1 reference

3 December 2017

volume

308

1 reference

3 December 2017

issue

2

1 reference

3 December 2017

page(s)

403-407

1 reference

Immune stimulating activity of two new chitosan containing adjuvant formulations

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901407-4

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901407-4

Selective inhibition of cyclooxygenase-2 by NS-398 in endotoxin shock rats in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901407-4

NS-398 treatment after trauma modifies NF-kappaB activation and improves survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901407-4

Elevated expression of cyclooxygenase-2 contributes to immune dysfunction in a murine model of trauma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901407-4

Trauma-induced alterations in macrophage function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901407-4

Trauma peptide-mediated prostaglandin E2 biosynthesis: a potential mechanism for trauma-induced immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901407-4

Cyclooxygenase-2 inhibitor NS-398 improves survival and restores leukocyte counts in burn infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901407-4

Blocking prostaglandin E2 after trauma attenuates pro-inflammatory cytokines and improves survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901407-4

Chitinous materials inhibit nitric oxide production by activated RAW 264.7 macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901407-4

Nitric oxide production by high molecular weight water-soluble chitosan via nuclear factor-kappaB activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901407-4

Expression of cyclooxygenase-2 in foetal rat hepatocytes stimulated with lipopolysaccharide and pro-inflammatory cytokines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901407-4

Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901407-4

Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901407-4

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901407-4

Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901407-4

Biological properties of interleukin 10.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901407-4

10.1016/S0006-291X(03)01407-4

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference